http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104906122-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d708a07486c27db90c59dff5b44f364 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706 |
| filingDate | 2015-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17d81c4307deb4f94ad631c07f86a5ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ece44aa50e11bc6e90184339ce68a3fd |
| publicationDate | 2015-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104906122-A |
| titleOfInvention | Application of capsicastrine in preparing anti-tumor drugs |
| abstract | The invention discloses application of capsicastrine in preparing anti-tumor drugs. By means of the in vitro inhibition test on the in vitro tumor cell and the anti-tumor effect observation of capsicastrine, the result shows that the capsicastrine plays a certain inhibition role on the lung cancer and the colon cancer, has obvious anti-tumor activity and is small in toxic and side effect. The capsicastrine and auxiliary materials capable of being accepted medically are manufactured together to obtain the anti-tumor drugs, and the dosage form of the drugs is one of the injection, the capsula, the tablet, the granula, the pill, the mixture and the oral liquid. |
| priorityDate | 2015-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.